Kaplan-Meier analysis of clinical outcomes in critical COVID-19

Por um escritor misterioso
Last updated 02 outubro 2024
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Medicina, Free Full-Text
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Frontiers High mortality rates among COVID-19 intensive care
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Tocilizumab improves 28-day survival in hospitalized patients with
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Tocilizumab in Hospitalized Patients with Severe Covid-19
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
COVID, Free Full-Text
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Simvastatin in Critically Ill Patients with Covid-19
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Trends in survival during the pandemic in patients with critical
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
A survival analysis of COVID-19 in the Mexican population
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Use of machine learning to assess the prognostic utility of
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Outpatient anti-spike monoclonal antibody administration is
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Clinical & laboratory data of COVID-19 patients:Saudi Arabia
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Antibiotics, Free Full-Text
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Hepatobiliary long-term consequences of COVID-19: dramatically
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Clinical and treatment factors associated with the mortality of
Kaplan-Meier analysis of clinical outcomes in critical COVID-19
Long-term survival after intensive care for COVID-19: a nationwide

© 2014-2024 digiamaz.ir. All rights reserved.